Enhancing the QUAlity and Transparency Of health Research

EQUATOR resources in German | Portuguese | Spanish

Reporting guidelines under development for systematic reviews


Reporting guidelines under development for systematic reviews, systematic reviews-related papers and PRISMA extensions

(year of development in brackets)

PRISMA-PC – Preferred Reporting Items for Systematic reviews and Meta-Analysis – Protocols for Children (2014)

PRISMA-C – Preferred Reporting Items for Systematic reviews and Meta-Analysis – Reporting for Children(2014)

PRISMA-RR – an extension to PRISMA for rapid reviews (2015)

PRISMA-TCM Statement – Preferred Reporting Items for Systematic Review and Meta-Analyses of traditional Chinese medicine (2016)

PRISMA-Search – guidelines for reporting systematic review literature searches (2016)

PRIOR – Preferred Reporting Items for Overviews of Review (2017)

PRISMA statement Update – Preferred Reporting Items for Systematic reviews and Meta-Analyses (2017)

PRISMA-Ethics – an extension to PRISMA for SRs on ethics literature (2018)

Preferred Reporting Items for Systematic reviews and Meta-Analyses – PRISMA Extension of Preclinical In Vivo Animal Experiments (2020)

PRISMA-COSMIN – Recommendations for Reporting Systematic Reviews of Outcome Measurement Instruments (2020)

Minimum standards for content and format of meta-data and data reporting in systematic reviews (2020)

Back to top

Preferred Reporting Items for Systematic reviews and Meta-Analysis – Protocols for Children (PRISMA-PC) (registered 6 November 2014)

An official extension of the PRISMA-P Statement defining standard protocol items for systematic review in children is currently under development. A Delphi process to generate possible reporting standards for PRISMA-PC and a consensus meeting have taken place in 2015. The evidence synthesis, Delphi survey and international consensus have been completed. The checklists have been finalized (available on request). This information has been updated on June 2020.

Read the project summary
Details on this project can be found here: PRISMA-Children (C) and PRISMA-Protocol for Children (P-C) Extensions: a study protocol for the development of guidelines for the conduct and reporting of systematic reviews and meta-analyses of newborn and child health research.
Visit the EnRICH Website
Contact: Dr Martin Offringa, martin.offringa@sickkids.ca

Back to top

Preferred Reporting Items for Systematic reviews and Meta-Analysis – Reporting for Children (PRISMA-C) (registered 6 November 2014)

An official extension of the PRISMA 2009 Statement defining standard reporting items for systematic review in children is currently under development. A Delphi process to generate possible reporting standards for PRISMA-C and a consensus meeting have taken place in 2015. The evidence synthesis, Delphi survey and international consensus have been completed. The checklists have been finalized (available on request). PRISMA-C Statement and Explanation and Elaboration document are expected to be published Q3 2020.

Read the project summary
Details on this project can be found here: PRISMA-Children (C) and PRISMA-Protocol for Children (P-C) Extensions: a study protocol for the development of guidelines for the conduct and reporting of systematic reviews and meta-analyses of newborn and child health research.
Visit the EnRICH Website
Contact: Dr Martin Offringa, martin.offringa@sickkids.ca

Back to top

PRISMA-RR: an extension to PRISMA for rapid reviews (registered 4 November 2015)

This reporting guideline will address reporting for rapid reviews, including those with analogous terminology (e.g., rapid evidence synthesis, rapid knowledge synthesis).

Read the project protocol (February 2018)
September 2017 update: stage 1 of the guidance is for rapid reviews that include primary studies. Following the completion of stage 1, guidance for rapid reviews that include secondary evidence, such as systematic reviews, will be developed and aligned with the development of the PRIOR reporting guideline (currently under development).
July 2018 update: Development of the reporting guideline is being undertaken in tandem with the update of PRISMA, http://prisma-statement.org/News
Contact: Adrienne Stevens, adstevens@ohri.ca

Back to top

Preferred Reporting Items for Systematic Review and Meta-Analyses of traditional Chinese medicine: the PRISMA-TCM Statement (registered 18 August 2016)

The objective is to develop and implement a guideline for reporting systematic reviews and meta-analyses in TCM, as a stand-alone extension to the PRISMA. The guideline contains 1) PRISMA for Chinese herb medicine, and 2) PRISMA for moxibustion.

Website: http://cmcs.hkbu.edu.hk/
Contact: Bian Zhao-Xiang, Chair Professor in Chinese Medicine Hong Kong Baptist University, bianzxiang@gmail.com

Back to top

PRISMA-Search: guidelines for reporting systematic review literature searches (registered 17 February 2016)

Read the protocol (February 2016)
Contact: Melissa Rethlefsen (mlrethlefsen@gmail.com), Jonathan Koffel (jbkoffel@umn.edu), Shona Kirtley (shona.kirtley@csm.ox.ac.uk

Back to top

Preferred Reporting Items for Overviews of Reviews (PRIOR) (registered 4 January 2017)

This guideline will address the reporting of overviews of reviews. Overviews are increasingly popular knowledge synthesis products that compile data from multiple systematic reviews to provide a single synthesis of relevant evidence for decision-making. We intend to focus the guideline on reporting overviews of healthcare interventions.

Read the development statement
Read the protocol
Contact: Lisa Hartling (primary contact), hartling@ualberta.ca; Michelle Pollock (alternate contact), michelle.pollock@ualberta.ca; Ricardo Fernandes (alternate contact), rmfernandes@campus.ul.pt

Back to top


Update of the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement (registered 13 December 2017)

An official update of the PRISMA 2009 statement defining standard reporting items for systematic reviews and meta-analyses is currently under development. We will conduct a review of the literature to identify items that could be modified, added, or removed from the PRISMA 2009 checklist. We will then complete a Delphi survey among a panel of journal editors, systematic reviewers, methodologists and end-users (e.g. policymakers, guideline developers, patients), to assess the appropriateness of potential items to include in the updated PRISMA checklist. We will also invite the panel to nominate other items for consideration. During an in-person consensus meeting in late 2018, the PRISMA update group will finalize a core set of items to be included in the updated PRISMA checklist. We plan to submit a paper presenting the updated PRISMA checklist, and a revised explanation and elaboration document, to an open-access journal. We will also develop a comprehensive knowledge translation strategy to help journals endorse and implement the guideline.

Read the protocol for the update of this guideline (February 2018)
Contact: Matthew Page, Monash University, matthew.page@monash.edu

Back to top

PRISMA-Ethics: an extension to PRISMA for SRs on ethics literature (registered 4 October 2018)

This PRISMA extension will take into account the characteristics of systematic reviews (SRs) on literature about ethically sensitive topics. The methods for search and selection will be very close to those applied in “traditional”, i.e. quantitative SRs, using empirical literature. But as SRs on ethically sensitive topics primarily involve conceptual and qualitative analyses and syntheses, these particularities need to be reflected in a reporting guideline (a more comprehensive definition of the scope/the type of literature will be given in the upcoming publication). For the extension of PRISMA, the PRISMA as well as the ENTREQ statement for qualitative research are used as a basis.  The group plans to publish the reporting guideline as an open-access paper in the Summer of 2019.

In a constituting session, the executive group agreed on the following steps:

Consensus discussion on a PRISMA checklist extension for ethics literature based on PRISMA and ENTREQ (face-to-face workshop and teleconference) – already done;
Consensus discussion on explanation and elaboration texts for the items on the adapted PRISMA checklist (written and verbal exchange/teleconference) – in the process of drafting texts for explanation and elaboration; the first discussion round planned was to take place in December 2018;
Finalisation of the checklist but also of the explanations and elaborations texts. The planned face-to-face workshop will particularly incorporate the feedback of potential users of the reporting guideline, such as editors and researchers, as well as potential users of published SRs on ethics literature, e.g. clinicians, policymakers, and ethics guideline developers – planned for 2019.
Contact: Hannes Kahrass (Kahrass.Hannes@mh-hannover.de), Marcel Mertz (Mertz.Marcel@mh-hannover.de), and Daniel Strech (daniel.strech@charite.de)

 

Back to top


Preferred Reporting Items for Systematic reviews and Meta-Analyses – PRISMA Extension of Preclinical In Vivo Animal Experiments (registered 12 March 2020)

This reporting guideline is an extension to the Preferred Reporting Items for Systematic reviews and Meta-Analysis (PRISMA), specifically for systematic reviews research performed in preclinical, in vivo animal models. The guideline development will occur in five phases: 1) Group establishment to help and provide expertise in the guideline development; 2) A cross-sectional study to describe the characteristics of and assess the reporting of contemporary preclinical systematic reviews; 3) Delphi Exercise; 4) Written Guidance; and 5) Dissemination.
The Core Group (n=14 to date) will lead the development and dissemination of the guidelines and includes members with expertise in various disciplines pertinent to guideline development, systematic reviews and meta-analysis, and in vivo animal experiments. This group formed in Fall 2018 and finalized its membership in February 2020. The group have performed an environmental scan by systematically searching the literature for published preclinical systematic reviews and have identified and synthesized the characteristics of these reviews in Summer 2019. The Delphi will start in Summer 2020 and finish in Fall 2020. The group aims to finalize the guidelines and have the results of the environmental scan and conference proceedings submitted for publication by Winter 2021.

The protocol for the overall project has been publicly posted on Open Science Framework at https://osf.io/g4kqz/. Within this project, the protocols for the cross-sectional study and the Delphi study have been posted as project components.
Contact: Dr Manoj M. Lalu, The Ottawa Hospital Research Institute (Clinical Epidemiology Program) Ottawa, Canada, mlalu@toh.ca

Back to top


PRISMA-COSMIN – Recommendations for Reporting Systematic Reviews of Outcome Measurement Instruments  (registered 22 September 2020)

The COnsensus based Standards for the selection of health Measurement INstruments (COSMIN) initiative developed outcome measurement instruments (OMIs) appraisal tools to aid in the selection of the most suitable OMIs for health research and clinical practice settings. However, recent evidence shows that key information, such as methods for evaluating the OMI measurement properties, is often missing in the reports of studies. Clear and complete reporting of the knowledge synthesis and OMI appraisal process is essential to ensure that the best OMIs have been selected and are fit-for-purpose and that health measurements are valid, reliable, patient-centred, and are comparable across research studies and health systems. A group from Canada aims to improve the quality of the reporting of systematic reviews conducted to assess OMIs. They will base the reporting guideline on the PRISMA checklist. The development will include a scoping review to generate candidate items, a three-round international Delphi study with expert consensus meeting, content validation, feasibility, and reliability testing of PRISMA-COSMIN across key areas of health research, and dissemination. The group plans to finish and publish the open-access document in 2023.

Protocol available at https://osf.io/rvd6z/ 

Contact: Nancy Butcher and Martin Offringa. Research Institute, The Hospital for Sick Children, Department of Paediatrics and University of Toronto/Institute of Health Policy. E-mail: enrich.network@sickkids.ca

Back to top

 

 

 

Minimum standards for content and format of meta-data and data reporting in systematic reviews (registered 14 October 2020)

Reporting transparency many times involves making available sets of data that are related to the main research report. The way these materials are uploaded to online platforms interferes with the discoverability by systematic reviewers. With that in mind, this group is proposing a guideline with a list of minimum requirements for the formatting of files, especially regarding meta-data, to allow machine readability and reuse. They plan to set standards for the reporting of all decisions taken during the study retrieval, selection, data extraction, and critical appraisal processes of a systematic review. For the description of the content and format, they want to be able to specify the file format (e.g. .txt, .ris, .csv, .json as opposed to .pdf, .docx., or .accdb) and the internal structure of the document (e.g. field tags for .ris formats, which field tag should contain eligibility decision tags at each level of screening). A longer-term aim is to encourage that data to have doi numbers and are freely accessible (FAIR/Open Data) through data archiving.

The guidance will apply to all systematic reviews, irrespective of the discipline, including reviews in sustainability, climate change, healthcare, international development, environmental science, social welfare, etc.

The group is planning a Delphi-style process and a future multidisciplinary expert panel to reach consensus.

Contact: Neal Haddaway, Stockholm Environment Institute. E-mail: neal.haddaway@sei.org

Back to top

 

Page last updated on 14 October 2020